| 2.9 |
11.8 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 2.9 |
11.7 |
GO:0010903 |
negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 1.9 |
5.8 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 1.8 |
5.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 1.8 |
5.4 |
GO:0010901 |
regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 1.6 |
3.3 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 1.5 |
4.4 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
| 1.4 |
19.1 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 1.3 |
5.1 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 1.3 |
6.3 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 1.2 |
3.7 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 1.2 |
3.6 |
GO:1990170 |
detoxification of cadmium ion(GO:0071585) stress response to cadmium ion(GO:1990170) |
| 1.2 |
11.6 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 1.2 |
4.6 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 1.1 |
4.6 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 1.1 |
3.3 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.1 |
3.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 1.1 |
3.3 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 1.0 |
3.1 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 1.0 |
3.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.0 |
1.0 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) ether lipid metabolic process(GO:0046485) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.0 |
5.9 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 1.0 |
2.9 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 1.0 |
2.9 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.0 |
6.8 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.9 |
1.9 |
GO:0070255 |
regulation of mucus secretion(GO:0070255) negative regulation of mucus secretion(GO:0070256) |
| 0.9 |
2.8 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.9 |
5.5 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.9 |
15.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.9 |
21.6 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.8 |
2.5 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.8 |
5.8 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.8 |
5.8 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.8 |
2.4 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.8 |
2.4 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.8 |
4.0 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.8 |
7.9 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.8 |
3.1 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.8 |
1.5 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.8 |
0.8 |
GO:0080135 |
regulation of cellular response to stress(GO:0080135) |
| 0.8 |
2.3 |
GO:0046368 |
GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) GDP-L-fucose metabolic process(GO:0046368) |
| 0.8 |
2.3 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.7 |
2.2 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.7 |
1.5 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.7 |
6.6 |
GO:0006069 |
ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
| 0.7 |
1.5 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.7 |
6.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.7 |
0.7 |
GO:0030516 |
regulation of axon extension(GO:0030516) |
| 0.7 |
3.6 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.7 |
2.9 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.7 |
37.7 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.7 |
5.7 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.7 |
1.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.7 |
0.7 |
GO:0071364 |
response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.7 |
2.7 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
| 0.7 |
2.0 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.7 |
2.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 |
2.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 |
3.3 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.6 |
1.9 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.6 |
2.6 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.6 |
2.6 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 0.6 |
1.9 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.6 |
3.8 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.6 |
3.2 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.6 |
6.3 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.6 |
2.5 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.6 |
0.6 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.6 |
1.2 |
GO:0048541 |
Peyer's patch development(GO:0048541) |
| 0.6 |
6.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.6 |
2.5 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.6 |
2.5 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) snRNA transport(GO:0051030) |
| 0.6 |
3.1 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.6 |
5.5 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.6 |
1.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.6 |
3.0 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.6 |
3.0 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.6 |
1.2 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.6 |
3.5 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.6 |
2.3 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.6 |
1.2 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.6 |
1.7 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.6 |
0.6 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.6 |
1.7 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.6 |
6.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.6 |
8.8 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.5 |
4.9 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.5 |
17.5 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.5 |
2.1 |
GO:2001259 |
positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
| 0.5 |
1.6 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.5 |
1.5 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.5 |
2.5 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.5 |
1.0 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.5 |
3.0 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.5 |
1.5 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.5 |
1.5 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.5 |
1.9 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 |
1.4 |
GO:0071104 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.5 |
1.4 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 |
1.9 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.5 |
2.8 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.5 |
0.5 |
GO:0006090 |
pyruvate metabolic process(GO:0006090) |
| 0.5 |
3.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.5 |
0.5 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.4 |
1.3 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.4 |
0.9 |
GO:0072125 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.4 |
2.7 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.4 |
2.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.4 |
3.5 |
GO:0051323 |
metaphase(GO:0051323) |
| 0.4 |
1.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.4 |
1.3 |
GO:0090467 |
L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.4 |
1.3 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.4 |
3.0 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 0.4 |
3.0 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.4 |
1.7 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.4 |
4.2 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.4 |
1.3 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.4 |
2.1 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.4 |
3.8 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.4 |
1.2 |
GO:0001832 |
blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
| 0.4 |
1.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 |
2.8 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.4 |
2.4 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.4 |
2.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.4 |
0.8 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.4 |
0.8 |
GO:1902622 |
regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
| 0.4 |
2.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.4 |
1.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 |
0.8 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.4 |
0.8 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 |
0.4 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.4 |
3.7 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.4 |
0.7 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.4 |
1.5 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.4 |
5.8 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.4 |
1.1 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.4 |
1.4 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.4 |
1.1 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.4 |
2.1 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.4 |
3.5 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.3 |
1.0 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 |
0.3 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.3 |
1.4 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.3 |
2.7 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.3 |
0.7 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.3 |
1.0 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.3 |
4.0 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.3 |
1.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
3.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
1.7 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
1.0 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.3 |
1.0 |
GO:0097237 |
cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 0.3 |
2.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 |
3.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
2.3 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.3 |
0.6 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
1.3 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.3 |
0.3 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.3 |
0.3 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.3 |
0.9 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
| 0.3 |
0.6 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.3 |
0.9 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.3 |
0.9 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.3 |
1.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
2.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.3 |
0.9 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.3 |
0.9 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.3 |
0.9 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.3 |
1.5 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.3 |
2.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
1.8 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.3 |
2.7 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.3 |
0.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.3 |
0.9 |
GO:0002575 |
basophil chemotaxis(GO:0002575) |
| 0.3 |
0.3 |
GO:0048659 |
smooth muscle cell proliferation(GO:0048659) |
| 0.3 |
0.9 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.3 |
4.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.3 |
2.0 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
| 0.3 |
7.1 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 |
1.1 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.3 |
0.6 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
1.1 |
GO:0060694 |
regulation of cholesterol transporter activity(GO:0060694) |
| 0.3 |
2.0 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.3 |
0.3 |
GO:0001820 |
serotonin secretion(GO:0001820) |
| 0.3 |
3.3 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.3 |
1.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
0.8 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.3 |
1.4 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 |
0.8 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.3 |
0.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
2.2 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.3 |
3.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.3 |
0.3 |
GO:0032196 |
transposition, DNA-mediated(GO:0006313) transposition(GO:0032196) |
| 0.3 |
1.3 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.3 |
0.3 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
2.4 |
GO:0032464 |
regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
3.4 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.3 |
1.0 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.3 |
0.3 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 |
1.0 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 |
0.3 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.3 |
1.5 |
GO:0061025 |
membrane fusion(GO:0061025) |
| 0.3 |
0.8 |
GO:0044340 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.3 |
4.5 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.3 |
0.5 |
GO:1901652 |
response to peptide(GO:1901652) |
| 0.3 |
1.0 |
GO:0034695 |
response to prostaglandin E(GO:0034695) |
| 0.2 |
1.0 |
GO:0072180 |
nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
| 0.2 |
1.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
1.2 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.2 |
1.2 |
GO:0009820 |
alkaloid metabolic process(GO:0009820) |
| 0.2 |
0.5 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.2 |
0.7 |
GO:0031427 |
response to methotrexate(GO:0031427) |
| 0.2 |
1.0 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.2 |
2.4 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.2 |
1.2 |
GO:0006919 |
activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.2 |
0.7 |
GO:0034126 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) positive regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034126) |
| 0.2 |
0.9 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.2 |
1.7 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.2 |
0.7 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
2.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
0.9 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.2 |
1.4 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
0.9 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.2 |
1.4 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
0.7 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.2 |
0.9 |
GO:0045423 |
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.2 |
1.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
1.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 |
1.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 |
1.6 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.2 |
1.1 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.2 |
0.2 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.2 |
0.7 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
| 0.2 |
0.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
2.0 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.2 |
1.1 |
GO:0010535 |
regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
| 0.2 |
0.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.7 |
GO:0048075 |
regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
| 0.2 |
0.4 |
GO:0002902 |
regulation of B cell apoptotic process(GO:0002902) |
| 0.2 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
1.3 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.2 |
1.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.4 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.2 |
0.4 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
1.7 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
0.9 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.2 |
GO:1902624 |
positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.2 |
1.5 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.2 |
1.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.2 |
3.6 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.2 |
0.2 |
GO:0031622 |
regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
| 0.2 |
0.4 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
| 0.2 |
0.2 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 |
0.6 |
GO:0006216 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 |
4.8 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.2 |
0.8 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.2 |
0.6 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.2 |
0.2 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.2 |
0.6 |
GO:0031167 |
rRNA modification(GO:0000154) rRNA methylation(GO:0031167) |
| 0.2 |
1.2 |
GO:0051294 |
establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
| 0.2 |
1.0 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.2 |
1.6 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.2 |
4.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
0.6 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.2 |
0.6 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.2 |
12.5 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.2 |
0.6 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 |
2.8 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.2 |
1.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
0.2 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) |
| 0.2 |
1.0 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.2 |
0.8 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.2 |
0.4 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.2 |
0.6 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.2 |
1.0 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.2 |
1.2 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.2 |
1.3 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.2 |
2.6 |
GO:0070192 |
synapsis(GO:0007129) homologous chromosome segregation(GO:0045143) chromosome organization involved in meiotic cell cycle(GO:0070192) |
| 0.2 |
0.9 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
3.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.2 |
0.2 |
GO:0009607 |
response to biotic stimulus(GO:0009607) |
| 0.2 |
2.1 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.2 |
0.6 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
1.1 |
GO:0009450 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.2 |
1.5 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.2 |
0.7 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 |
0.6 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 |
0.4 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
0.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.2 |
0.9 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.2 |
0.2 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.2 |
1.1 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.2 |
0.6 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.5 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.2 |
0.5 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.2 |
1.3 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.2 |
1.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.2 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.2 |
0.9 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.2 |
0.5 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.2 |
0.2 |
GO:0060896 |
neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
| 0.2 |
2.5 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.2 |
0.5 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 |
0.4 |
GO:0052510 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 |
0.4 |
GO:0051938 |
L-glutamate import(GO:0051938) |
| 0.2 |
0.7 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
1.9 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
0.3 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.2 |
4.3 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.2 |
0.5 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
| 0.2 |
6.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.2 |
0.5 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
2.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 |
0.2 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.2 |
0.3 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.2 |
3.1 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.2 |
0.3 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.2 |
0.2 |
GO:0002864 |
regulation of acute inflammatory response to antigenic stimulus(GO:0002864) |
| 0.2 |
15.3 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.2 |
2.5 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.2 |
0.5 |
GO:0046146 |
tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
0.7 |
GO:1901698 |
response to nitrogen compound(GO:1901698) |
| 0.2 |
0.3 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 |
0.7 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
0.7 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
| 0.2 |
1.0 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 |
0.7 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
3.8 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.2 |
0.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
1.8 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
0.3 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.2 |
1.1 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.5 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
| 0.2 |
0.5 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.2 |
0.5 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.2 |
1.1 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.2 |
0.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.5 |
GO:0071848 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 |
0.6 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
1.0 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
0.6 |
GO:0090267 |
regulation of spindle checkpoint(GO:0090231) positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.2 |
0.2 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.2 |
1.0 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 |
0.5 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
| 0.2 |
0.3 |
GO:0090101 |
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) |
| 0.2 |
1.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.2 |
4.8 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 |
0.2 |
GO:0003018 |
vascular process in circulatory system(GO:0003018) |
| 0.2 |
0.9 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.2 |
0.6 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
1.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
0.3 |
GO:0010594 |
regulation of endothelial cell migration(GO:0010594) |
| 0.2 |
1.4 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.2 |
0.5 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
1.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
0.3 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 |
1.8 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.6 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
1.8 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.4 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.1 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
1.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.1 |
1.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.4 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.1 |
0.7 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
0.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.3 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
0.4 |
GO:0051293 |
establishment of mitotic spindle localization(GO:0040001) establishment of spindle localization(GO:0051293) spindle localization(GO:0051653) |
| 0.1 |
0.7 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.4 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.1 |
0.3 |
GO:0006200 |
obsolete ATP catabolic process(GO:0006200) |
| 0.1 |
1.0 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
0.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
1.0 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.7 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.6 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.4 |
GO:0045953 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
2.3 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.1 |
0.3 |
GO:0009124 |
nucleoside monophosphate biosynthetic process(GO:0009124) |
| 0.1 |
0.8 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
1.5 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.4 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
1.4 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.4 |
GO:0046080 |
dUTP metabolic process(GO:0046080) |
| 0.1 |
0.4 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 |
1.8 |
GO:0001775 |
cell activation(GO:0001775) |
| 0.1 |
0.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.3 |
GO:0042455 |
ribonucleoside biosynthetic process(GO:0042455) |
| 0.1 |
1.6 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.3 |
GO:0050678 |
regulation of epithelial cell proliferation(GO:0050678) |
| 0.1 |
0.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.1 |
2.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.4 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.3 |
GO:0030072 |
peptide hormone secretion(GO:0030072) |
| 0.1 |
0.3 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.8 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.4 |
GO:0060744 |
thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.9 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.1 |
GO:0061024 |
membrane organization(GO:0061024) |
| 0.1 |
2.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.8 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.5 |
GO:0030147 |
obsolete natriuresis(GO:0030147) |
| 0.1 |
0.4 |
GO:0072205 |
collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
| 0.1 |
5.1 |
GO:0042593 |
carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.1 |
0.4 |
GO:0045835 |
tyrosine phosphorylation of Stat1 protein(GO:0042508) negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
2.2 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
1.3 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.1 |
0.5 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.1 |
0.4 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
2.6 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.1 |
0.3 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.1 |
0.3 |
GO:0009220 |
pyrimidine nucleotide biosynthetic process(GO:0006221) pyrimidine ribonucleotide metabolic process(GO:0009218) pyrimidine ribonucleotide biosynthetic process(GO:0009220) |
| 0.1 |
0.3 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.1 |
0.5 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
2.4 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.1 |
0.4 |
GO:0010041 |
response to iron(III) ion(GO:0010041) regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) response to DDT(GO:0046680) positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) regulation of chromosome condensation(GO:0060623) cellular response to iron ion(GO:0071281) cellular response to iron(III) ion(GO:0071283) |
| 0.1 |
0.1 |
GO:0042119 |
granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
| 0.1 |
1.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.5 |
GO:0071354 |
cellular response to interleukin-6(GO:0071354) |
| 0.1 |
1.4 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.4 |
GO:0021871 |
forebrain regionalization(GO:0021871) telencephalon regionalization(GO:0021978) |
| 0.1 |
0.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.7 |
GO:0006772 |
thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
| 0.1 |
0.4 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.1 |
1.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
2.1 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.1 |
0.5 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
0.2 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.1 |
0.2 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.1 |
0.4 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
0.1 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.7 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.2 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
1.6 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 |
1.5 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.1 |
0.5 |
GO:0051276 |
chromosome organization(GO:0051276) |
| 0.1 |
1.2 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.1 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.1 |
0.3 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.7 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
0.6 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.5 |
GO:0022605 |
oogenesis stage(GO:0022605) |
| 0.1 |
0.3 |
GO:2000858 |
renin-angiotensin regulation of aldosterone production(GO:0002018) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) positive regulation of NAD(P)H oxidase activity(GO:0033864) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.1 |
4.0 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.1 |
0.5 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
3.1 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
0.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.7 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.3 |
GO:0070561 |
vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) vitamin D catabolic process(GO:0042369) vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.3 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.7 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.8 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
1.0 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
3.1 |
GO:0030866 |
cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.7 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.1 |
0.2 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.4 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
0.5 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
| 0.1 |
1.2 |
GO:0031055 |
DNA replication-independent nucleosome assembly(GO:0006336) chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.2 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.5 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
0.2 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
0.9 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
| 0.1 |
0.5 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
2.4 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
1.8 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 |
2.1 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
1.3 |
GO:0005977 |
glycogen metabolic process(GO:0005977) |
| 0.1 |
0.7 |
GO:0045926 |
negative regulation of growth(GO:0045926) |
| 0.1 |
0.1 |
GO:0006029 |
proteoglycan metabolic process(GO:0006029) |
| 0.1 |
0.6 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
0.3 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.1 |
0.8 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
1.8 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.1 |
0.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
1.7 |
GO:0019827 |
stem cell population maintenance(GO:0019827) |
| 0.1 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
4.5 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.1 |
0.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
2.2 |
GO:0009451 |
RNA modification(GO:0009451) |
| 0.1 |
0.3 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.1 |
0.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.1 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
2.6 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.1 |
0.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.1 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
1.0 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
2.0 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
0.1 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
1.0 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
2.9 |
GO:0051781 |
positive regulation of cell division(GO:0051781) |
| 0.1 |
0.7 |
GO:1900087 |
traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.2 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
2.0 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.1 |
1.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.9 |
GO:0010821 |
regulation of mitochondrion organization(GO:0010821) |
| 0.1 |
0.4 |
GO:0045299 |
otolith mineralization(GO:0045299) |
| 0.1 |
0.6 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
2.2 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 0.1 |
7.3 |
GO:0000236 |
mitotic prometaphase(GO:0000236) |
| 0.1 |
0.7 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.2 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
2.4 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.1 |
GO:0033262 |
obsolete telomere maintenance via telomere shortening(GO:0010834) regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
0.5 |
GO:0035246 |
peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 |
0.9 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.1 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.1 |
1.3 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.1 |
1.7 |
GO:0050848 |
regulation of calcium-mediated signaling(GO:0050848) |
| 0.1 |
0.3 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.1 |
1.4 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
0.3 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.1 |
0.1 |
GO:2000831 |
steroid hormone secretion(GO:0035929) corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
| 0.1 |
0.3 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
1.5 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.3 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.4 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
1.0 |
GO:0030641 |
regulation of cellular pH(GO:0030641) |
| 0.1 |
0.2 |
GO:0071220 |
response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
| 0.1 |
0.8 |
GO:0042438 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 |
0.3 |
GO:0070071 |
proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.1 |
0.6 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
1.2 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
0.1 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.3 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.3 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 |
1.9 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.3 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
2.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.8 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
0.6 |
GO:0007179 |
transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) transforming growth factor beta receptor signaling pathway(GO:0007179) response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.1 |
0.1 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.6 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.3 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.3 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.2 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.1 |
3.1 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.1 |
0.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.8 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.6 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.2 |
GO:0060603 |
mammary gland duct morphogenesis(GO:0060603) |
| 0.1 |
0.6 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
1.2 |
GO:0002286 |
T cell activation involved in immune response(GO:0002286) |
| 0.1 |
0.2 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.1 |
1.6 |
GO:0001707 |
mesoderm formation(GO:0001707) |
| 0.1 |
0.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.5 |
GO:0007097 |
nuclear migration(GO:0007097) nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.1 |
1.6 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.2 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
0.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
0.2 |
GO:0006538 |
glutamate catabolic process(GO:0006538) glutamate decarboxylation to succinate(GO:0006540) |
| 0.1 |
1.1 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.1 |
6.1 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.1 |
0.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.1 |
0.3 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.1 |
0.2 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
0.2 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.2 |
GO:0017157 |
regulation of exocytosis(GO:0017157) |
| 0.1 |
0.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.3 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.1 |
0.1 |
GO:0021575 |
hindbrain morphogenesis(GO:0021575) cerebellum morphogenesis(GO:0021587) |
| 0.1 |
0.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.1 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.2 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.5 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
| 0.1 |
0.3 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.4 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
0.1 |
GO:0007199 |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 0.1 |
0.6 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
9.1 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.1 |
0.1 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.3 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
1.7 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.1 |
0.6 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
2.2 |
GO:0033572 |
ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 |
0.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
1.0 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.1 |
0.2 |
GO:0046033 |
AMP biosynthetic process(GO:0006167) AMP metabolic process(GO:0046033) |
| 0.1 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
0.2 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.1 |
0.5 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.1 |
3.1 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
0.1 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.4 |
GO:0060487 |
lung epithelial cell differentiation(GO:0060487) |
| 0.1 |
1.6 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.3 |
GO:0030878 |
thyroid gland development(GO:0030878) |
| 0.1 |
0.5 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 |
1.6 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
0.3 |
GO:0030099 |
myeloid cell differentiation(GO:0030099) |
| 0.1 |
0.3 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.8 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.1 |
0.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
0.3 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
2.9 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.1 |
0.5 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
0.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.2 |
GO:0070384 |
trachea cartilage development(GO:0060534) Harderian gland development(GO:0070384) |
| 0.1 |
0.2 |
GO:0055117 |
regulation of cardiac muscle contraction(GO:0055117) |
| 0.1 |
0.2 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 |
0.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
5.6 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 |
0.5 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.1 |
0.7 |
GO:0002687 |
positive regulation of leukocyte migration(GO:0002687) |
| 0.1 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.1 |
GO:0060014 |
granulosa cell differentiation(GO:0060014) |
| 0.1 |
1.0 |
GO:0040014 |
regulation of multicellular organism growth(GO:0040014) |
| 0.1 |
0.1 |
GO:0006922 |
obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
| 0.1 |
0.1 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 |
0.2 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.1 |
GO:0045061 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) thymic T cell selection(GO:0045061) |
| 0.1 |
0.5 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.2 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.1 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.1 |
0.2 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.6 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.1 |
1.3 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.2 |
GO:0010629 |
negative regulation of gene expression(GO:0010629) |
| 0.1 |
2.8 |
GO:0071357 |
response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.5 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.2 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 |
0.9 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.2 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.1 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
1.0 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 |
0.2 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.1 |
0.1 |
GO:0021940 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 |
0.3 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.1 |
0.1 |
GO:0071428 |
rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.1 |
0.7 |
GO:0042596 |
behavioral fear response(GO:0001662) fear response(GO:0042596) |
| 0.1 |
0.4 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.4 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
1.4 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.5 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.1 |
0.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.2 |
GO:0098657 |
neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
| 0.1 |
0.4 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.2 |
GO:0071436 |
sodium ion export(GO:0071436) |
| 0.1 |
0.2 |
GO:0001552 |
ovarian follicle atresia(GO:0001552) |
| 0.0 |
1.4 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.2 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.0 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.0 |
0.6 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.3 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.0 |
0.8 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
0.5 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0043501 |
skeletal muscle adaptation(GO:0043501) |
| 0.0 |
0.0 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
0.3 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.0 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.0 |
0.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:0002124 |
territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) vocalization behavior(GO:0071625) |
| 0.0 |
0.2 |
GO:0090329 |
regulation of DNA-dependent DNA replication(GO:0090329) |
| 0.0 |
0.4 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.0 |
0.4 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.0 |
1.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.4 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.0 |
0.3 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.2 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.0 |
0.1 |
GO:0060122 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.2 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.0 |
0.5 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.0 |
0.3 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.0 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
| 0.0 |
0.1 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.1 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 |
1.0 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 |
0.2 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.0 |
0.5 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 |
0.2 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.0 |
0.2 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
1.8 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.0 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.1 |
GO:0021533 |
cell differentiation in hindbrain(GO:0021533) |
| 0.0 |
0.3 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
| 0.0 |
1.1 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.2 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 |
0.1 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 |
0.8 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
1.0 |
GO:0036503 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
| 0.0 |
2.2 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 0.0 |
0.1 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
| 0.0 |
2.5 |
GO:0019318 |
hexose metabolic process(GO:0019318) |
| 0.0 |
0.1 |
GO:0060968 |
regulation of gene silencing(GO:0060968) |
| 0.0 |
0.1 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
2.0 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.3 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) negative regulation of cell projection organization(GO:0031345) |
| 0.0 |
0.1 |
GO:0021754 |
facial nucleus development(GO:0021754) |
| 0.0 |
0.5 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.4 |
GO:0045885 |
obsolete positive regulation of survival gene product expression(GO:0045885) |
| 0.0 |
1.2 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.5 |
GO:0046632 |
alpha-beta T cell differentiation(GO:0046632) |
| 0.0 |
0.0 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
1.7 |
GO:0034339 |
obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.0 |
0.0 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:0071801 |
podosome assembly(GO:0071800) regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.1 |
GO:0032508 |
DNA geometric change(GO:0032392) DNA duplex unwinding(GO:0032508) |
| 0.0 |
5.3 |
GO:0050776 |
regulation of immune response(GO:0050776) |
| 0.0 |
1.4 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.9 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
4.7 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 |
0.4 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.1 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) sphingoid catabolic process(GO:0046521) |
| 0.0 |
0.4 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
0.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.1 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.4 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.5 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
1.2 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
| 0.0 |
0.2 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.1 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.0 |
0.3 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 |
0.3 |
GO:0048892 |
sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
| 0.0 |
0.1 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.0 |
0.1 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.0 |
GO:0032743 |
positive regulation of interleukin-2 production(GO:0032743) |
| 0.0 |
0.1 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 |
0.1 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.0 |
0.9 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) regulation of lymphocyte differentiation(GO:0045619) |
| 0.0 |
0.1 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 |
0.2 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
4.5 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.0 |
0.0 |
GO:0000819 |
sister chromatid segregation(GO:0000819) nuclear chromosome segregation(GO:0098813) |
| 0.0 |
0.1 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
0.2 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.3 |
GO:0006448 |
regulation of translational elongation(GO:0006448) |
| 0.0 |
0.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.0 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0031113 |
regulation of microtubule polymerization(GO:0031113) |
| 0.0 |
0.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) midbrain-hindbrain boundary development(GO:0030917) |
| 0.0 |
0.1 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.0 |
2.9 |
GO:0055074 |
calcium ion homeostasis(GO:0055074) |
| 0.0 |
0.0 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.0 |
0.3 |
GO:0010463 |
mesenchymal cell proliferation(GO:0010463) |
| 0.0 |
0.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.2 |
GO:0007162 |
negative regulation of cell adhesion(GO:0007162) |
| 0.0 |
6.4 |
GO:0007283 |
spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.0 |
0.0 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.1 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.1 |
GO:0048070 |
regulation of developmental pigmentation(GO:0048070) |
| 0.0 |
0.5 |
GO:0048469 |
cell maturation(GO:0048469) |
| 0.0 |
0.2 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.1 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
6.6 |
GO:0006955 |
immune response(GO:0006955) |
| 0.0 |
0.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.0 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.1 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.0 |
GO:0009063 |
cellular amino acid catabolic process(GO:0009063) |
| 0.0 |
2.2 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.6 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.0 |
0.2 |
GO:0016073 |
snRNA metabolic process(GO:0016073) snRNA processing(GO:0016180) |
| 0.0 |
0.2 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.0 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.0 |
0.0 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) |
| 0.0 |
0.2 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.4 |
GO:0051925 |
obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.0 |
0.2 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.0 |
0.1 |
GO:0045666 |
positive regulation of neuron differentiation(GO:0045666) |
| 0.0 |
0.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.2 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.0 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) chondrocyte development(GO:0002063) |
| 0.0 |
0.2 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.0 |
GO:0031034 |
skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.1 |
GO:0003416 |
endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
| 0.0 |
0.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.0 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.0 |
GO:0048002 |
antigen processing and presentation(GO:0019882) antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.0 |
0.1 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
0.0 |
GO:0090184 |
positive regulation of kidney development(GO:0090184) |
| 0.0 |
0.1 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.0 |
0.0 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.0 |
GO:0001892 |
embryonic placenta development(GO:0001892) |
| 0.0 |
0.3 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.0 |
0.0 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.0 |
0.0 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.0 |
0.1 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.0 |
0.6 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.3 |
GO:0007416 |
synapse assembly(GO:0007416) |
| 0.0 |
0.0 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.0 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.0 |
0.1 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.0 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.0 |
GO:0003077 |
obsolete negative regulation of diuresis(GO:0003077) |
| 0.0 |
0.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
1.9 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
0.1 |
GO:0048593 |
camera-type eye morphogenesis(GO:0048593) |
| 0.0 |
0.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.1 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 |
0.0 |
GO:0006598 |
polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
| 0.0 |
0.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.1 |
GO:0032868 |
response to insulin(GO:0032868) |
| 0.0 |
0.1 |
GO:0060326 |
cell chemotaxis(GO:0060326) |
| 0.0 |
0.1 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
